SKŘIČKOVÁ, Jana, Zbyněk BORTLÍČEK, Karel HEJDUK, M. PEŠEK, V. KOLEK, L. KOUBKOVÁ, Marcela TOMÍŠKOVÁ, J. ROUBEC, P. ZATLOUKAL a F. SALAJKA. Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts). In 13th Central European Lung Cancer Conference. 2012. ISSN 0169-5002. Dostupné z: https://dx.doi.org/10.1016/j.lungcan.2012.05.074. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{989264, author = {Skřičková, Jana and Bortlíček, Zbyněk and Hejduk, Karel and Pešek, M. and Kolek, V. and Koubková, L. and Tomíšková, Marcela and Roubec, J. and Zatloukal, P. and Salajka, F.}, booktitle = {13th Central European Lung Cancer Conference}, doi = {http://dx.doi.org/10.1016/j.lungcan.2012.05.074}, keywords = {lung cancer; erlotinib}, language = {eng}, title = {Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)}, year = {2012} }
TY - CONF ID - 989264 AU - Skřičková, Jana - Bortlíček, Zbyněk - Hejduk, Karel - Pešek, M. - Kolek, V. - Koubková, L. - Tomíšková, Marcela - Roubec, J. - Zatloukal, P. - Salajka, F. PY - 2012 TI - Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts) KW - lung cancer KW - erlotinib N2 - The Czech Republic has had an opportunity to use pemetrexed for 1st line treatment of advanced NSCLC from the year 2008. The purpose of this trial was to evaluate the activity and feasibility of pemetrexed in 1st line treatment NSCLC patients. ER -
SKŘIČKOVÁ, Jana, Zbyněk BORTLÍČEK, Karel HEJDUK, M. PEŠEK, V. KOLEK, L. KOUBKOVÁ, Marcela TOMÍŠKOVÁ, J. ROUBEC, P. ZATLOUKAL a F. SALAJKA. Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts). In \textit{13th Central European Lung Cancer Conference}. 2012. ISSN~0169-5002. Dostupné z: https://dx.doi.org/10.1016/j.lungcan.2012.05.074.
|